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Summary
Leishmania mexicana has a large family of cyclin-
dependent kinases (CDKs) that reflect the complex
interplay between cell cycle and life cycle progres-
sion. Evidence from previous studies indicated that
Cdc2-related kinase 3 (CRK3) in complex with the
cyclin CYC6 is a functional homologue of the major
cell cycle regulator CDK1, yet definitive genetic evi-
dence for an essential role in parasite proliferation is
lacking. To address this, we have implemented an
inducible gene deletion system based on a dimerised
Cre recombinase (diCre) to target CRK3 and elucidate
its role in the cell cycle of L. mexicana. Induction of
diCre activity in promastigotes with rapamycin
resulted in efficient deletion of floxed CRK3, resulting
in G2/M growth arrest. Co-expression of a CRK3
transgene during rapamycin-induced deletion of
CRK3 resulted in complementation of growth,
whereas expression of an active site CRK3T178E
mutant did not, showing that protein kinase activity
is crucial for CRK3 function. Inducible deletion of
CRK3 in stationary phase promastigotes resulted in
attenuated growth in mice, thereby confirming CRK3
as a useful therapeutic target and diCre as a valuable
new tool for analyzing essential genes in Leishmania.
Introduction
The leishmaniases, diseases caused by protozoan para-
sites of the genus Leishmania, have diverse clinical mani-
festations dependent on the species and host immune
response. Leishmaniasis is a substantial public health
issue, causing an estimated 40,000 deaths annually and
approximately 0.2–0.4 and 0.7–1.2 million visceral and
cutaneous manifestations of the disease respectively
(Alvar et al., 2012). Existing drug therapies are problematic
because of high treatment costs, toxicity and undesirable
administration routes, making the development of novel
and effective drug therapies to expand the current reper-
toire crucial. Phenotypic strategies to identify drug targets
in the mammalian infective amastigote life cycle stage are
of particular importance for drug discovery programs.
As unicellular organisms, Leishmania depend on strin-
gent control of cellular division to propagate and main-
tain infection. Protein kinases elicit pronounced effects
on the Leishmania cell cycle by regulation of cell signal-
ling pathways, and a number of protein kinases have
been identified that are essential for promastigote viabil-
ity (Dacher et al., 2014; Wang et al., 2005). The cyclin-
dependent kinases (CDK) are of particularly interest
because of their pivotal roles as cell cycle regulators.
The use of CDK inhibitors in cancer therapy (Cicenas
and Valius, 2011; Knapp and Sundstr€om, 2014) and the
relative expansion of this protein family in Leishmania
relative to other unicellular organisms distinguishes
them as suitable drug targets. In particular, the CDK-
related kinase CRK3 has been demonstrated as being
important for regulation of the L. mexicana promastigote
cell cycle by existing genetic manipulation techniques
and cell cycle arrest following treatment with CDK inhibi-
tors (Hassan et al., 2001; Grant et al., 1998; 2004).
Recombinant protein kinase activity assays (Gomes
et al., 2010) and yeast recovery mutants (Wang et al.,
1998) have provided further validation of CRK3 as a
drug target, leading to the identification and synthesis of
a number of CRK3 inhibitors (Cleghorn et al., 2011;
Goyal et al., 2014; Grant et al., 2004; Reznıcˇkova
et al., 2015; Walker et al., 2011). Regulation of CRK3
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expression in L. mexicana is desirable to further assess
its function in both procyclic promastigote and amasti-
gote life cycle stages, however, no system exists for
conditional deletion of essential genes. Recent applica-
tion of plasmid shuffle methodology has addressed this
issue by enabling the generation of partial null mutants
to further study essentiality and important residues
within coding sequences (Dacher et al., 2014; Morales
et al., 2010), however, the gene is not deleted and this
prevents phenotyping of a null mutant.
To address this limitation, we have implemented a
rapamycin-inducible gene deletion system using a
dimerised Cre recombinase (diCre) (Andenmatten et al.,
2013; Collins et al., 2013; Jullien et al., 2003) to target
CRK3 and elucidate its role in the cell cycle of L. mexi-
cana. L. mexicana is generally diploid (Rogers et al.,
2011) and both CRK3 alleles were replaced with a
‘floxed’ CRK3 open reading frame and the diCre coding
sequence through promastigote transfection and homol-
ogous recombination. This system was used to condi-
tionally delete CRK3 during promastigote growth and so
prove that CRK3 mediates the transition through G2/M.
Induced loss of CRK3 was complemented by expression
of a CRK3 transgene but not by expression of an inac-
tive site (T178E) CRK3 mutant, showing that protein
kinase activity is crucial for CRK3 function. Significantly,
conditional deletion of CRK3 in stationary phase pro-
mastigotes and subsequent attenuation during murine
infection demonstrates that CRK3 activity is essential for
establishing infection. This system represents a new
method to directly assess whether a gene is essential to
parasite viability and provides novel insight into the func-
tion of essential genes in Leishmania.
Results
DiCre activity is tightly regulated in L. mexicana
promastigotes and amastigotes
To test the activity of diCre in L. mexicana promasti-
gotes, a reporter cell line was generated by integration
of a loxP-flanked GFP into the ribosomal locus: [SSU
GFPFlox]. This cell line was transfected with a diCre con-
struct containing the two dimerizable Cre recombinase
subunits with the homologous flanks of crk3 to generate
the heterozygous line (Dcrk3::DICRE/CRK3 [SSU
GFPFlox]). Integration of the diCre construct at the CRK3
locus was confirmed by PCR analysis (Fig. S1A). No
effect on the growth of SSU GFPFlox or Dcrk3::DICRE/
CRK3 [SSU GFPFlox] was observed in the presence of
the dimerization ligand, rapamycin, up to the highest
dose of 250 nM (Fig. S1B). GFP excision following incu-
bation with increasing concentrations of rapamycin was
investigated by PCR using specific primers flanking
GFP. A single 1.45 kb PCR product, the floxed GFP
fragment, was detected in the absence of rapamycin,
whilst a 0.69 kb PCR product, representing the excised
locus, was detected following rapamycin treatment only
(Fig. 1A), indicating tight regulation of diCre activity.
Dcrk3::DICRE/CRK3 [SSU GFPFlox] and [SSU GFPFlox]
promastigotes grown for 5 days in the presence or
absence of increasing concentrations of rapamycin were
analyzed by flow cytometry to measure levels of GFP
expression (Fig. 1B). Treatment of Dcrk3::DICRE/CRK3
[SSU GFPFlox] promastigotes with greater than 5 nM
rapamycin resulted in substantial loss of GFP expres-
sion compared with the untreated controls, whilst GFP
expression in [SSU GFPFlox] was the same following
growth in all concentrations of rapamycin. GFP loss in
Dcrk3::DICRE/CRK3 [SSU GFPFlox] promastigotes
grown in the presence or absence of 100 nM rapamycin
for 5 days was further assessed by Western blotting of
total protein extracts using anti-GFP antibody (Fig. 1C).
Rapamycin-treated promastigotes had considerably
reduced GFP compared with the untreated controls,
thereby demonstrating that gene loss results in reduced
protein expression. These data also demonstrate that
expression of diCre from the CRK3 locus is sufficient to
efficiently excise the GFP transgene at rapamycin con-
centrations above 5 nM, and that no background diCre
activity can be detected in the absence of ligand. About
100 nM of rapamycin was chosen as the optimum con-
centration to induce diCre activity in promastigotes
whilst having no effect on in vitro cell growth.
To test diCre functionality in amastigotes, infectious pro-
mastigotes of the experimental line Dcrk3::DICRE/CRK3
[SSU GFPFlox] were inoculated into BALB/c footpads and
amastigotes purified from the resulting lesion. Ex vivo amas-
tigotes retained high levels of green fluorescence and were
incubated with rapamycin for 24 h in Schneider’s medium
prior to infection of bone-marrow derived macrophages. Effi-
cient excision of GFPFlox was detected by PCR amplification
of a 0.69 kb fragment representative of GFP loss in all rapa-
mycin treated samples (Fig. 1D) and GFP- (non-fluorescent)
amastigotes were observed by comparing images obtained
through fluorescence live cell imaging (Fig. S1C). Residual
GFP1 amastigotes were still visible by microscopy (Fig.
S1C) and could be detected by flow cytometry (Fig. S1D);
this was possibly because of the slow replication rate of
amastigotes leading to a low rate of GFP turnover. These
data demonstrate inducible diCre activity in amastigotes.
Inducible deletion of CRK3 in L. mexicana
promastigotes
The functional and efficient levels of diCre-mediated
excision of GFP underpinned the development of a
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system for conditional deletion of essential genes. Gate-
way recombineering was used to flank appropriate diCre
and loxP expression constructs with gene-specific,
homologous flanks (Fig. S2). Plasmids were generated
by this method to replace the two alleles of CRK3, an
essential gene in L. mexicana (Hassan et al., 2001) (Fig
S3A). The first allele of CRK3 was replaced with
DICRE (Dcrk3::DICRE/CRK3) and the second allele of
CRK3 was subsequently replaced with a floxed C-
terminal GFP-tagged CRK3 version (Dcrk3::DICRE/
Dcrk3::CRK3Flox; Figs. 2A and S3B). In addition, an
mCherry red fluorescent protein coding sequence was
incorporated downstream from the floxed CRK3-GFP to
facilitate flow cytometry and microscopy analysis. Trans-
fection resulted in multiple clones with the expected
genetic modifications, as confirmed by PCR analysis
(Fig. S3B).
The growth of promastigotes from two Dcrk3::DICRE/
Dcrk3::CRK3Flox clones were assessed following diCre-
mediated excision induced with 100 nM rapamycin (Fig.
2B). Cells were counted over the course of 5 days,
revealing a pronounced growth defect and reduction in
cell number in rapamycin-treated cells compared with
uninduced controls. PCR analysis of promastigotes
grown in the presence or absence of 100 nM rapamycin
for 24 and 48 h confirmed efficient loss of the CRK3
gene (Fig. 2C) by the amplification of a single 1.36 kb
DNA fragment for both rapamycin-treated clones. The
retention of the 3.4 kb amplicon containing the CRK3
gene in both untreated clones is evidence that no back-
ground diCre activity can be detected in the absence of
rapamycin. To test for loss of the CRK3-GFP protein,
total protein extracts of clone 2 promastigotes grown for
96 h in the presence or absence of 100 nM rapamycin
were analysed by Western blot analysis with anti-GFP
antibody (Fig. 2D) Very low levels of protein were
detected in the treated promastigotes compared to the
untreated cells, confirming that the conditional gene loss
Fig. 1. Validation of inducible diCre in L. mexicana: conditional deletion of GFP in promastigotes and amastigotes.
A. Gene excision analyzed by PCR amplification. Schematic (lower) shows the SSU GFPFlox locus and the recombination event expected
after treatment with rapamycin (Rap). (upper) PCR amplification with oligonucleotides 4287 and 4288 from experimental (Dcrk3::DICRE/CRK3
[SSU GFPFlox]) and control [SSU GFPFlox] promastigotes at 5 days post-treatment with different concentrations of rapamycin.
B. Flow cytometry assessment of GFP intensity of experimental and control promastigotes incubated in the presence or absence of rapamycin
for 5 days.
C. Western blotting analysis with anti-GFP and anti-EF1a loading control antibodies of protein extracted from experimental promastigotes
grown for 5 days in the presence or absence of 100 nM rapamycin.
D. PCR analysis of GFPFlox loss (as described in A) in amastigotes after 24 h rapamycin treatment (0–1000 nM), followed by 120 h infection
in bone-marrow derived macrophages. Lane 2 contains a 1 kb1 DNA ladder.
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leads to reduced protein levels. Treatment with 100 nM
rapamycin did not result in any noticeable effect on L.
mexicana promastigote growth (Fig. S1B), however the
pronounced growth arrest arising from loss of the essen-
tial gene could possibly result in cellular stress that syn-
ergizes with rapamycin. These data show that this is a
viable genetic manipulation strategy and that loss of
CRK3 resulted in growth arrest and reduced cell num-
bers, both phenotypes consistent with loss of an essen-
tial gene.
Cell cycle analysis of CRK3-deficient promastigotes
Previous attempts to impair CRK3 function in Leishma-
nia by treatment with protein kinase inhibitors may have
resulted in off-target effects (Cleghorn et al., 2011;
Efstathiou et al., 2014; Grant et al., 2004; Jorda et al.,
2011; Reichwald et al., 2008; Reznıcˇkova et al., 2015).
Here the utilization of diCre mediated gene deletion
enabled the effect of CRK3 depletion on the cell cycle to
be investigated. Firstly, microscopic analysis of the cells
Fig. 2. Generation of a CRK3 conditional deletion cell line.
A. Schematic showing the replacement of endogenous CRK3 to generate Dcrk3::DICRE/Dcrk3::CRK3Flox. One allele contains a loxP flanked
CRK3-GFP coding sequence with mCherry red-fluorescent protein cassette (RFP) and puromycin drug selectable marker (PAC). The other
allele contains genes encoding both diCre subunits (CRE59, CRE60) each linked with rapamycin binding domains (not shown: FKBP12 and
FRB respectively) and a blasticidin resistance cassette (BSD). Each construct was flanked with 500 bp arms of homology (light grey)
by Gateway recombination to facilitate integration at the CRK3 locus. All coding sequences are flanked by regulatory elements (dark grey).
L. mexicana parasites were transfected sequentially with the diCre construct and floxed CRK3 to confer resistance to blasticidin and
puromycin antibiotics respectively.
B. Clones 2 and 8 promastigotes were seeded at a density of 53105 cells mL21 and grown in the presence or absence (1/2) of 100 nM
rapamycin for 5 days. Cell density was determined by counting at 24 h intervals and mean6SD of triplicate values was plotted.
C. (lower) A schematic representation of the floxed CRK3 locus after excision. PCR amplification shows the primers binding upstream of
the 50 CRK3 homologous flank and within the PAC cassette. (upper) PCR amplification of clones 2 and 8 at 24 h and 48 h 1/2100 nM
rapamycin treatment was conducted and the resulting amplicons resolved on an agarose gel.
D. Western blotting analysis with anti-GFP and anti-EF1a loading control antibodies of protein extracted from experimental clone 2
promastigotes grown for 4 days in the presence or absence of 100 nM rapamycin.
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at 96 h post-induction showed an accumulation of large,
aberrant cells with altered organelle homeostasis as evi-
denced by the presence of cells with multiple flagella
(Fig. 3A). DAPI labelling of such multi-flagellated cells to
visualize cellular DNA revealed the presence of enlarged
nuclei indicative of an arrest in mitosis. Interestingly,
cells were also observed that lacked a nucleus but
retained the kinetoplast (‘zoids’), a cell cycle defect
observed previously by the treatment of promastigotes
with CDK inhibitors (Grant et al., 2004). Secondly, flow
cytometry was performed to determine the overall DNA
content of Dcrk3::DICRE/Dcrk3::CRK3Flox promastigotes
grown in the presence or absence of 100 nM rapamycin
for 72 and 96 h (Fig. 3B). This analysis showed that
conditional deletion of CRK3 resulted in the accumula-
tion of cells with 4C DNA content, associated with cell
Fig. 3. Analysis of CRK3 deficient promastigotes.
A. Representative images of cells grown in the absence (top) or presence (bottom two rows) of 100 nM rapamycin for 96 h. Promastigotes
(clone 2) were stained with DAPI to observe nuclear and kinetoplast content alongside mCherry expression by fluorescence microscopy. Scale
bar represents 5 lm.
B. (upper) DNA content analysis of clone 2 promastigotes at 72 and 96 h post-treatment. Cells were fixed with methanol and stained with
propidium iodide for flow cytometry analysis of 100,000 cells to examine nuclear content. Arrows indicate the positions of cells in G1 phase
(2C), in G2/M (4C) and low DNA content associated with increased incidence of <1C zoids. (lower) Graphical representation of the DNA
content of each population based on the flow cytometry plots.
C. The viability of cells grown in the absence (2) or presence (1) of 100 nM rapamycin for 72 h. Promastigotes (clone 2) were incubated with
5 mg mL21 propidium iodide (PI) for 15 min and analyzed by flow cytometry. A heat lysed (HL) control in which half the sample was lysed by
incubation at 708C for 3 min was included to enable an appropriate live/dead gate to be drawn. Numbers represent the percentage of cells
assessed as PI positive (PI1) based on the HL control. Data shown are the means of three technical replicates, data are representative of
two independent experiments.
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cycle arrest at G2/M, whilst an increasing population of
cells with DNA content <1C indicates the accumulation
of zoids. Finally, to assess the rate of cell death occur-
ring in CRK3-deficient cells a viability assay was per-
formed on promastigotes after growth in the presence
or absence of 100 nM rapamycin for 72 h (Figs. 3C
and S4). After 72 h the proportion of propidium iodide
positive cells (PI1) was around 40% indicating a high
level of cell death, which likely resulted from the accu-
mulation of anucleated zoids at this time point. Flow
cytometry analysis of cell size (using forward scatter)
was in agreement with the microscopy analysis and
showed that CRK3 deficient cells were substantially
larger than cells retaining the gene (Fig. S4). Taken
together, these data provide evidence that CRK3 plays
an essential role in regulating mitosis in replicating
promastigotes.
Active CRK3 is required for cell cycle progression
in promastigotes
We demonstrated that diCre could be used to efficiently
delete a floxed copy of CRK3, so we exploited the effi-
ciency of this system to further study gene function
through complementation. Such a system was estab-
lished by expressing a histidine-tagged CRK3 (CRK3his)
(Hassan et al., 2001) transgene in Dcrk3:DICRE/
Dcrk3::CRK3Flox promastigotes. No significant difference
in growth was noted in the presence or absence of
rapamycin over a 5 day period (Fig. 4A). Efficient exci-
sion of floxed CRK3 in the induced culture was con-
firmed by PCR amplification of the diagnostic 1.36 kb
fragment by 24 h post-treatment with 100 nM rapamycin
(Fig. 4B). The proliferation of promastigotes, despite
loss of floxed CRK3, indicates CRK3 transgene
Fig. 4. CRK3 wild type and active site mutant complementation assays.
A. Wild type complemented (Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU CRK3], left graph) and mutant complemented (Dcrk3::DICRE/
Dcrk3::CRK3Flox [SSU CRK3T178E], right graph) cell lines were seeded as promastigotes at 13 105 cells mL21 and grown 1/2 100 nM
rapamycin for 5 days. Cell density was determined by counting at 24 h intervals and the mean6SD of triplicate values was plotted.
B. The resulting amplicons generated by PCR amplification of each cell line at 24 and 48 h after growth 1/2 100 nM rapamycin.
C. (left) DNA content analysis of Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU CRK3T178E] promastigotes after methanol fixation and staining with
propidium iodide for flow cytometry analysis (100,000 cells) to examine nuclear content. Arrows indicate the positions of cells in G1 phase
(2C), in G2 (4C) and low DNA content associated with increased incidence of <2C zoids. (right) Graphical representation of the DNA content
of each population based on the flow cytometry analysis.
D. Representative images of Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU CRK3T178E] promastigotes grown in the absence (top) or presence (bottom
two rows) of 100 nM rapamycin for 96 h. Parasites were stained with DAPI to detect nuclear and kinetoplast DNA by fluorescence microscopy.
Scale bar represents 5 lm.
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complementation in the induced Dcrk3 cell line. Previous
studies have shown that recombinant L. mexicana
CRK3T178E protein lacks H1 kinase activity (Gomes
et al., 2010) and an L. major CRK3T178E mutant fails to
complement a cdc2-33(ts) yeast mutant (Wang et al.,
1998). To test whether active CRK3 is required for cell
growth, we exploited this complementation approach by
generation of the cell line Dcrk3::DICRE/Dcrk3::CRK3Flox
[SSU CRK3T178E] expressing a T-loop residue mutated
version of CRK3 from the ribosomal locus. Growth
curves indicate that expression of the CRK3T178E trans-
gene failed to complement the loss of CRK3Flox follow-
ing induction with rapamycin (Fig. 4A and B) thereby
demonstrating that CRK3T178E cannot rescue loss of
active CRK3. The overall growth rate of both comple-
mentation mutants was reduced relative to the parental
line (Table 1) and may explain the growth arrest at 72 h
following excision of CRK3 in Dcrk3::DICRE/
Dcrk3::CRK3Flox [SSU CRK3T178E] compared with a
more rapid onset of growth arrest in the parental line
(Fig. 2B). These data show that active CRK3 is required
for parasite growth. The CRK3 deficient cells were ana-
lyzed by flow cytometry and fluorescence microscopy
showing that Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU
CRK3T178E] cells were blocked in G2/M (Fig. 4C) and
were multi-nucleate and aberrant (Fig. 4D). These data
are in agreement with the phenotype observed following
excision of CRK3 in wild-type cells (Fig. 3A and B),
thereby indicating the importance of the T-loop in regu-
lating CRK3 activity. Based on these results, we con-
clude that transgene complementation can be used to
confirm the specificity of conditional deletion of essential
genes and also to probe the function of genes following
mutagenesis.
CRK3 is essential for in vivo infection of murine hosts
The lack of a conditional system to regulate expression
of essential genes is a major obstacle for in vivo studies
of essentiality, with such studies having crucial applica-
tions for drug target validation. To address this we
tested if CRK3 activity is essential for survival of the
parasite over the course of in vivo infection. Monitoring
infection by detection of the light signal emitted from
bioluminescent Leishmania using an in vivo imaging
system (IVIS) is an established, longitudinal and nonin-
vasive method to correlate signal with pathogen load
(Lang et al., 2005; Lecoeur et al., 2007; Talmi-Frank
et al., 2012; Vasquez et al., 2015). To assess the out-
come of CRK3 loss on the proliferation of L. mexicana
in vivo, bioluminescent lines were generated by transfec-
tion of L. mexicana wild-type and Dcrk3::DICRE/
Dcrk3::CRK3Flox promastigotes with a ribosomal integra-
tion construct encoding red-shifted firefly luciferase, Ppy
RE9H (Branchini et al., 2010; McLatchie et al., 2013).
Both lines were bioluminescent as determined by lucifer-
ase expression assays on logarithmic stage promasti-
gotes. The resulting Dcrk3::DICRE/Dcrk3::CRK3Flox
[SSU RE9H] cell line produced five fold higher biolumi-
nescence compared with the wild-type [SSU RE9H] con-
trol (Fig. S4). Footpad bioluminescence detected with
an in vivo imaging system (IVIS) correlated well with
parasite burden in mice infected with L. mexicana
expressing Ppy RE9H (Fig. 5A; y5 4.81 0.43x,
R25 0.743 and p< 0.0001). The slope of the linear
regression line (0.43) revealed smaller increases in bio-
luminescence with increasing parasite burden. This may
be related to tissue absorbance of light in vivo or limited
substrate availability with increasing numbers of amasti-
gotes within the lesion. Nevertheless, these data show
that parasite burdens can be predicted from biolumines-
cence and that IVIS could be used for the non-invasive
monitoring of parasite growth in mice over 10 weeks of
infection. Following treatment of Dcrk3::DICRE/
Dcrk3::CRK3Flox stationary phase promastigotes with
rapamycin for 24 h the amplification of a 1.36 kb frag-
ment (Fig. 5B) indicated that the majority of parasites
had successfully excised floxed CRK3. The presence of
small amounts of a 3.4 kb amplicon corresponding to
the intact floxed CRK3 gene, however, also suggested
that some parasites had retained the gene. These sta-
tionary phase Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU
RE9H] promastigotes either rapamycin treated (1Rap)
or not treated (2Rap) were then inoculated into the foot-
pads of BALB/c mice. The in vivo bioluminescence in
footpads of mice infected with the rapamycin-treated
Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU RE9H] was signifi-
cantly reduced compared to the uninduced control by 5
weeks post-infection (p< 0.001) and this continued up
to 9 weeks post-infection (p<0.005) (Fig. 5C and D).
From 5 to 9 weeks the bioluminescence from footpads
infected with rapamycin-treated parasites increased 100
fold and was likely because of the proliferation of para-
sites that had not responded to rapamycin treatment
and persisted in the lesion. To investigate this possibility,
viable amastigotes were purified from the lesions of four
mice at 10 weeks post-infection and analyzed for the
presence of CRK3Flox by PCR after a single round of
Table 1. Comparisons of the growth rates of conditional CRK3
deletion lines measured during logarithmic growth.
Experimental Line
Doubling
Time (hrs)
Dcrk3::DICRE/Dcrk3::CRK3Flox 10.6
Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU CRK3] 15.5
Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU CRK3T78E] 13.6
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in vitro culture (Fig. 5E). A 3.4 kb PCR product contain-
ing CRK3 was amplified from all samples, indicating the
persistence of parasites that had escaped diCre medi-
ated excision of CRK3.
The ability of CRK3 deficient promastigotes to estab-
lish infection was further assessed by measuring foot-
pad sizes at weekly intervals (Fig. 5F). The footpad
sizes of mice infected with either untreated or
rapamycin-treated Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU
RE9H] parasites were similarly low until about 4 weeks
post-infection. Subsequently, footpads containing
untreated parasites increased steadily over the course
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of infection, whilst those infected with rapamycin-treated
Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU RE9H] remained
low until 9 weeks post-infection. Comparison of the bio-
luminescence and lesion sizes suggest that there is a
delay in lesion development despite parasite proliferation
and that the lesions only increase significantly when par-
asite load reaches a certain level (equating to biolumi-
nescence 107 photons/s); in the case of the untreated
parasites this occurred from about 5 weeks while for
rapamycin-treated parasites this level of parasite burden
had still not been reached by 9 weeks. Altogether these
data show that loss of active CRK3 impairs the estab-
lishment of infection in vivo, and that a later resurgence
of parasites likely results from a small population of cells
which previously escaped CRK3 conditional deletion.
Discussion
We have developed an inducible system for the genetic
manipulation of essential genes in Leishmania. Inducible
diCre was used to demonstrate the requirement for
CRK3 activity in the regulation of mitosis. A distinct
growth defect was observed 48 h after induced deletion
of CRK3 (Fig. 2) resulting in cells arrested in G2/M, as
well as an accumulation of zoids and eventually a popu-
lation of enlarged, multi-flagellated cells (Fig. 3). This
phenotype was rescued by expression of a CRK3 trans-
gene from the ribosomal locus, confirming that loss of
CRK3 caused mitotic arrest (Fig. 4). Arrest in G2/M and
the accumulation of zoids have previously been reported
following incubation of L. mexicana promastigotes with
the CRK3 inhibitors flavopiridol (Hassan et al., 2001)
and indirubin (Grant et al., 2004), showing correlation
between genetic and chemical downregulation of CRK3
activity. In Trypanosoma brucei RNAi knockdown of the
syntenic orthologue of CRK3 in the procyclic form also
results in G2/M arrest and zoid formation (Tu and Wang,
2004), with the accumulation of such aberrant cells
explained by the lack of a checkpoint controlling exit
from mitosis and entry in cytokinesis (Hammarton et al.,
2003; Ploubidou et al., 1999). Inducible deletion of
CRK3 indicates that this checkpoint is also absent in
L. mexicana promastigotes, resulting in impairment of
mitotic progression, followed by re-initiation of G1 in the
absence of cytokinesis. It appears that these abnormal
cells can eventually undergo cytokinesis; however the
daughter cell lacks a nucleus and is often multi-
flagellated (see bi-flagellated zoid in Fig. 3A), whilst the
high levels of cell death occurring 72 h after gene loss
show that such progeny are not viable.
CRK3 is active at different stages in the cell cycle by
forming complexes with cyclin partners such as CYC6
and CYCA, therefore CRK3 deletion could impact the
cell cycle at multiple stages. RNAi of the CYC6 in
T. brucei procyclic forms results in growth arrest within
48 h of induction and the accumulation of zoids and
cells in G2/M (Hammarton et al., 2003). A similar phe-
notype was found in this study with CRK3 inducible
deletion, suggesting that the CRK3:CYC6 complex is
involved in regulation of mitosis (Walker et al., 2011).
Less is known about the activity of CRK3:CYCA. Protein
expression assays of L. donovani CYC1 (the functional
orthologue of CYCA) demonstrates an increased abun-
dance during S-phase (Banerjee et al., 2006) coupled
with histone phosphorylation by an active CRK3:CYC1
complex (Maity et al., 2011), which is suggestive of
S-phase kinase activity. Active, recombinant L. mexi-
cana CRK3:CYCA has also been engineered, with
phosphorylation of the T-loop residue T178 by the CDK
activating kinase (CAK) Civ-1 increasing activity (Gomes
et al., 2010). The T178 residue is essential for CRK3
activity as T178E mutagenesis inhibits functional rescue
in S. pombe (Wang, 1998) and ablates kinase activity in
recombinant CRK3T178E:CYCA (Gomes et al., 2010).
The necessity of T178 was tested directly in this study,
with excision of floxed CRK3 in the Dcrk3::DICRE/
Dcrk3::CRK3Flox [SSU CRK3T178E] line leading to cell
Fig. 5. CRK3 conditional deletion in stationary phase promastigotes and in vivo infection.
A. Correlation between in vivo bioluminescence (total flux in photons per second) and parasite burdens from the same infected footpads.
BALB/c mice were infected with L. mexicana WT or Ppy RE9H-expressing stationary phase promastigotes and imaged weekly using an in vivo
imaging system (IVIS). At 2, 4, 6 and 8 weeks post-infection mice were sacrificed after imaging and parasite burdens in infected footpads
determined using limiting dilution assays. Each point shows the total flux and parasite burden from the footpad in one mouse (n5 3–4 mice
per time point). Linear regression line and R2 was calculated from the log transformed data.
B. PCR amplification of the floxed CRK3 locus of Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU RE9H] stationary phase promastigotes after incubation
in the presence (1) or absence (2) of 1 lM rapamycin for 24 h.
C. Control (2) or 24 h rapamycin-treated (1) stationary phase promastigotes were inoculated into the footpads of BALB/c mice. The total flux
(photons/s) emitted from the infected footpad region of interest (ROI) was quantified weekly.
D. The total flux measured from infected footpads was plotted over 9 weeks of infection. Data shown represent the mean flux and SD from
groups of four mice. The dotted line indicates the average background flux emitted from uninfected footpads measured 1 week post infection
(n512). A significant difference in the mean total flux emitted between the footpads of mice infected with untreated and rapamycin-induced
parasites was observed at 5 and 9 weeks post-infection (2-way ANOVA, ***p 0.001; **p 0.005).
E. PCR amplification of the floxed CRK3 locus of Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU RE9H]1Rap after purification of amastigotes from the
footpads of 10-week infected mice. Cells were propagated in vitro to obtain sufficient genomic DNA for PCR analysis.
F. Footpad sizes were recorded by weekly caliper measurement. Data shown represent the mean footpad size and SD from groups of four
mice (Unpaired t-test *p 0.05).
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cycle arrest in G2/M and zoid formation. The growth
rate of this line and Dcrk3::DICRE/Dcrk3::CRK3Flox
[SSU CRK3] were reduced when compared to
Dcrk3::DICRE/Dcrk3::CRK3Flox (Table 1), indicative of
generally reduced growth rate when expressing a trans-
gene. Episomal complementation with CRK3 did not
result in an observable growth defect (Hassan et al.,
2001), but this may result from the modulation of the
number of episomal copies, as has been observed pre-
viously following complementation of the essential MCA
gene (Ambit et al., 2008). Integration into the 18s rRNA
locus results in consistently high levels of expression
(Misslitz et al., 2000) leading to nonphysiological levels
of CRK3 and subsequent CRK3:CYC6 activity at poten-
tially inappropriate stages of the life cycle.
The reduced growth rate of promastigotes overex-
pressing CRK3T178E is likely because of a partial domi-
nant negative effect, whereby inactive CRK3T178E binds
endogenous CYC6 leading to impaired protein kinase
activity even in the presence of active CRK3. This
reduced growth rate may explain both the cell cycle
arrest at 72 h in the [SSU CRK3T178E] complemented
line (Fig. 4A) compared to arrest at 48 h in
Dcrk3::DICRE/Dcrk3::CRK3Flox (Fig. 2B) and additionally
the lower proportion of zoids when analyzed by flow
cytometry (Fig. 4C). The accumulation in G2/M sug-
gests that mutation ablates CRK3:CYC6 activity, rather
than CRK3:CYCA, where an increase of cells in G1/S
might be anticipated. Both induced and uninduced
Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU CRK3T178E] have
dramatically reduced flagellum length and are immotile
(Fig. 4D). The reduced size of the flagellum and a
growth defect are similar phenotypes to those observed
in cell lines deficient in ATG5, a key component of the
autophagic pathway (Williams et al., 2012). This is likely
a result of their impaired ability to salvage material
through the autophagic pathway, imparting selection on
the parasites to reduce energy through flagellum regres-
sion. The partial dominant negative effect of CRK3T178E
may also result in metabolic stress in these cells leading
to the phenotype observed. The importance of T178 as
an active site residue for regulating progression through
G2/M implicates upstream modifiers of this residue as
essential regulators of the L. mexicana cell cycle. In
mammalian cells CDK7 acts as a CAK to regulate
CDK1 by phosphorylation at this T-loop residue, yet no
CAK homologues have been identified in the Leishma-
nia genome (Gomes et al., 2010). The identification of
potential post-transcriptional modifiers of the CRK3
T-loop residue that act in an analogous fashion to CDK7
would therefore yield promising targets for drug discov-
ery. The phenotype of the induced cell line shows the
importance of the T-loop residue for CRK3 activity and
mitotic function within the cell, endorsing this comple-
mentation assay as a rational approach for active site
investigation.
The assessment of gene essentiality for amastigote
viability is an important approach in the context of drug
target validation as this life cycle stage is the pathologi-
cally significant form. The recent utilization of plasmid
shuffle has facilitated the study of Leishmania genes
involved in life cycle differentiation and essentiality both in
amastigote and promastigote forms by the generation of
partial null mutants (Dacher et al., 2014; Morales et al.,
2010). Retention of an episomal gene in a null mutant
cell line after murine infection is a useful approach to
assess that gene as necessary to amastigote survival in
vivo (Wiese, 1998). Despite such elegant utilization of
reverse genetic methods to probe gene function, no
method exists for the generation of conditional null
mutants during in vivo infection. Our study does not
address this lack directly because of the sensitivity of
amastigotes to rapamycin, however as diCre activity
remains high in stationary-phase promastigotes CRK3
was efficiently excised (Fig. 5B) to probe the subsequent
infectivity of CRK3-deficient promastigotes. By tracking
the progression of infection with reporter parasites
expressing the highly sensitive red-shifted luciferase
(Branchini et al., 2010; McLatchie et al., 2013) and by
footpad size measurement, we demonstrate that the
CRK3-deficient L. mexicana are unable to proliferate in
their mammalian host (Figs. 5C, D, and F). Importantly,
the wild-type line expressing luciferase grows normally in
mice following rapamycin treatment, which indicates that
lack of growth of the CRK3-deficient mutant is not a
result of the drug treatment. The average light intensities
emitted from footpads infected with the wild-type [SSU
RE9H) line and those from footpads infected with the
Dcrk3::DICRE/Dcrk3::CRK3Flox [SSU RE9H] line retaining
floxed CRK3 are at similar levels throughout infection, yet
mean footpad size is larger in wild-type [SSU RE9H]
infected mice after 3 weeks post-infection; such disagree-
ment may be a result of the five fold lower signal intensity
of the wild-type [SSU RE9H] compared with the experi-
mental line (Fig. S5) and therefore an overall higher bur-
den of the wild-type line is likely masked by a reduced
bioluminescent signal intensity.
Interestingly, parasite burden as measured by total
flux remains consistently above the background intensity
(dashed line, Fig. 5D) in those footpads infected with
the CRK3-deficient line, suggestive of the survival of a
low number of bioluminescent parasites. The outgrowth
of these parasites was observed through an increased
bioluminescence signal at 9 weeks post-infection com-
pared with 5 weeks (Fig. 5C and D). Purification and
PCR analysis of these parasites show they retained the
floxed CRK3 (Fig. 5E) and that the persistence of signal
and subsequent increase are a result of incomplete
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excision of floxed CRK3 during the 24 h incubation with
rapamycin. These data further demonstrate the essen-
tiality of CRK3 activity for establishing infection.
This is the first time an essential gene in promasti-
gotes has been studied in vivo by conditional deletion,
representing a useful tool to probe gene function. We
are validating the feasibility of conditional gene deletion
ex vivo and in vivo using rapamycin and nonimmuno-
inhibitory rapamycin analogues (‘rapalogs’), with such
work being useful for the future of drug target validation.
DiCre activity has been demonstrated in vivo (Jullien
et al., 2007), however rapamycin treatment may be a
limitation because of influence on the host immune
response and on amastigote proliferation. Our attempts
to study the effect of CRK3Flox deletion in lesion-derived
amastigotes grown in axenic culture medium was prob-
lematic because of reduced proliferation of both experi-
mental and wild-type L. mexicana at the relatively low
dose of 50 nM rapamycin, therefore the use of rapalogs
would be a rational approach for induction of diCre
activity if they have reduced binding affinity for Leishma-
nia TORs (Madeira da Silva and Beverley, 2010). A sec-
ond generation diCre is currently in development and
may present an alternative method for inducible gene
deletion in vivo. In diCre2, each subunit is fused to
mutant FKBP domains that are dimerised by the rapalog
AP20187, which is amenable to in vivo use (Collins
et al., 2013). Such a system could be applied for use in
Leishmania and would complement our existing floxed
gene replacement approach.
In conclusion we have developed a highly efficient
inducible gene deletion system that when used with
transgene complementation allows for the first time the
function of essential Leishmania genes to be elucidated.
We have applied this approach to show that CRK3 is
required for promastigote progression through mitosis,
with gene deletion mutants showing a G2/M arrest and
an accumulation of zoids, indicative of a lack of a cell
cycle checkpoint in cytokinesis. Inducible deletion of
CRK3 in stationary phase promastigotes attenuates
infection in a murine host, providing further genetic vali-
dation of CRK3 as a potential drug target (Gomes et al.,
2010; Grant et al., 1998; 2004; Hassan et al., 2001;
Walker et al., 2011). Our diCre method provides a
powerful tool for analysing genes essential for promasti-
gote proliferation and to the study of the differentiation
of promastigotes to amastigotes.
Experimental procedures
Ethics statement
Animal studies were carried out under UK Home Office reg-
ulations (Project licence PPL 60/4442).
Parasite culture and transfection
Leishmania mexicana mexicana (MNYC/BZ/62/M379) pro-
mastigotes were cultured at 258C in HOMEM supplemented
with 10% heat inactivated foetal calf serum (HI-FCS) and
1% penicillin/streptomycin (PEN/STREP). Amastigotes
were cultured in Schneider’s Insect Medium supplemented
with 20% HI-FCS, 1% PEN/STREP and 15 lg mL21 Hemin
at pH5.5. Mid-log phase L. mexicana promastigotes were
transfected with 10 lg of digested DNA by electroporation
using the Nucleofector system with the Human T-Cell kit
(Lonza) as described previously (Castanys-Mu~noz et al.,
2012). Transgenic cell lines were grown in the presence of
appropriate antibiotics at the following concentrations: G418
50 lg mL21, blasticidin 10 lg mL21 and puromycin 10 lg
mL21 (InvivoGen).
Construct design and development
A full list and descriptions of all primers (Table S1) and
plasmids (Table S2) used in this study are available. To
produce a diCre expression vector, the diCre coding
sequences Cre59-FKBP12 and Cre60-FRB were each
flanked by actin and b-tubulin sequences in array with
blasticidin resistance cassette flanked by DHFR-TS regu-
latory elements. The sequence was synthesized and sub-
cloned into the pDONR221 vector (GenScript). The back-
bone of the loxP vector containing the loxP sites flanking a
multiple cloning site and other restriction enzyme regions
flanked by regulatory elements was synthesized (Gen-
Script). The PAC, mCherry and CRK3-GFP cassettes
were inserted by enzymatic restriction digest mediated
ligation, and subsequently sub-cloned into pDONR221.
Addition of CRK3 homology flanking homology was per-
formed by MultiSite Gateway 3-fragment vector construc-
tion (Invitrogen) as per manufacturers’ guidelines. Briefly,
flanks were amplified by PCR by Phusion polymerase
(New England BioLabs) using oligonucleotides conferring
attB recombination sites to the amplicons. Subsequent BP
reactions inserted the flanks into appropriate pDONR vec-
tors containing attL sites for site-specific recombination.
An LR reaction resulted in the flanking of diCre and loxP
vectors into a pDEST vector for transfection. Finally, com-
plementation plasmids were generated by inserting the
CRK3, CRK3T178E and RE9H genes (Branchini et al.,
2010; McLatchie et al., 2013) into a modified version of
pGL631 (Misslitz et al., 2000) containing a G418r cassette
for SSU integration construct by XhoI & NotI restriction
enzyme digestion and ligation.
Induction of diCre mediated gene deletion
All experiments were conducted using cells in the early to
mid log stage of exponential growth (between 1 and
53106 cells mL21) with the exception of the stationary
phase inducible gene deletion. Between 1 nM and 1 lM
rapamycin (Abcam) was administered by inoculation into
the cell culture medium from a 100 lM working stock.
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Conditional gene deletion analysis
Taq polymerase (NEB) was used to PCR amplify the
regions surrounding GFPFlox and CRK3Flox using primers
shown in Table S1 and a TA calculated using an online Tm
calculator (New England BioLabs) and 30 cycles for
amplification.
Western blot analysis
For western blotting analysis, either 13 107 cells were
loaded per lane or equal concentrations of protein extract
as quantified by Bradford assay of a 10% NuPAGE Bis-Tris
gel (Invitrogen) in MOPS running buffer and transferred
onto Hybond-C nitrocellulose membranes (GE Healthcare).
Primary antibodies against GFP were used to detect GFP
and CRK3-GFP expression at 1:1000 whilst anti-EF1a was
used as a loading control at 1:5000. Membranes were
washed three times in TBST, incubating for 10 min each
time, before incubation with horse radish peroxidase (HRP)-
conjugated secondary rabbit and mouse antibodies at
1:5000 dilution for 1 h at room temperature. After washing
three times in TBST, the membrane was treated with an
ECL (enhanced chemiluminescence) kit (SuperSignal West
Pico Chemoluminescent Substrate, Pierce) according to
manufacturer’s instructions and then exposed on Kodak
photographic film.
Infection of mice
BALB/c mice were purchased from Charles River (MA.,
USA) and infected in the right footpad with 23 106
stationary-phase L. mexicana promastigotes in 13PBS.
Lesion size was monitored weekly and Dcrk3::DICRE/CRK3
[SSU GFPFlox] amastigotes were purified before the lesions
reached a thickness of 5 mm.
Purification of lesion-derived amastigotes
Lesion-derived Dcrk3::DICRE/CRK3 [SSU GFPFlox] amasti-
gotes were purified by homogenizing the extracted lesion in
1xPBS and passing the solution through a 20 lm cell
strainer. Amastigotes were pelleted by centrifugation at
2000 g for 10 mins, followed by re-suspension in culture
medium. To prevent cells from clumping together and
ensure accurate cell counting, amastigote cultures were
first centrifuged at 2000 g for 10 mins and the supernatant
removed to leave the pellet in 500 lL volume. The pellet
was re-suspended in this volume by gentle syringing
through a blunt 16G needle and the single cell suspension
added back to the culture medium. Cell counting was per-
formed by mixing the homogenized culture 1:1 with Trypan
blue and cell counting with a Haemocytometer (Neubauer).
Macrophage differentiation and amastigote infection
Nondifferentiated monocytes were extracted from the
femurs and tibia of BALB/c mice by dissection to remove
the bones. RPMI 1640 medium was used to wash the bone
marrow out of the intact bones by syringing with a 25G
needle. Extracted cells were quantified by dilution in Trypan
blue (1:1) and counting with a haemocytometer. Monocytes
were seeded at 53105 cells mL21 in MU Medium
(DMEM1 L-Glut1 20%FCS1 1% P/S1 30% L-Cell M) in
8 mL volumes in Petri dishes and incubated at 378C with
5% CO2 for 3 days to induce differentiation to monocyte-
derived macrophage. After this period the medium was
replaced and by day 5 the cells were removed from the
dishes using a cell scraper with ice- cold RPMI 1640.
Bone-marrow derived macrophages were adhered at a
concentration of 53 105 cells mL21 overnight in DMEM
medium with 10% HIFCS at 378C in 5% CO2 onto
8-chamber tissue culture slides (LAB-TEK) for microscopic
analysis or 12 well plates for DNA extraction and flow
cytometry analysis. Macrophages were then infected at a
ratio of five parasites per macrophage with lesion-derived
Dcrk3::DICRE/CRK3 [SSU GFPFlox] amastigotes, which
had been previously grown in axenic medium in the pres-
ence or absence of rapamycin for 24 h. Wells were washed
at 24 h post-infection to remove extracellular parasites and
media replenished with DMEM/10% HIFCS. Cells were
removed from the plates for DNA extraction and flow
cytometry analysis by gentle scraping in ice cold RPMI at
the 120 h end time point.
Fluorescence microscopy analysis
For imaging, 23 106 parasites were washed in 13PBS, re-
suspended in Fluoromount-G (SouthernBiotech) DAPI
infused mounting medium and mounted on glass slides for
analysis. Parasite morphology was observed by DIC and
mCherry fluorescent imaging, and DNA content observed
by DAPI fluorescent imaging using a Delta Vision core
(Image Solutions) inverted microscope equipped with
mCherry and DAPI filter sets. Images were processed
using Photoshop CS (Adobe) image software. GFP expres-
sion of intracellular amastigotes was assessed by fluores-
cent microscopy. Cells were imaged between 24 and 120 h
after infection in the DeltaVision Core environmental cham-
ber at 378C and 5% CO2 upon incubation in 13PBS
infused with DAPI.
DNA content and GFP expression analysis by flow
cytometry
Parasites were prepared for DNA content analysis as
described previously (Paul Hassan et al., 2001) with the
exceptions that a MacsQuant flow cytometer was used to
analyze 100,000 cells per sample. Cell distribution was mod-
elled using FlowJo software (Tree Star). For determining
GFP expression of promastigotes and amastigotes by flow
cytometry analysis, live cells were washed twice in 1xPBS
and passed through a nitex mesh prior to acquisition.
Viability assay
Log-phase promastigotes were seeded at 53 105 cells
mL21 and grown in the presence or absence of 100 nM
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rapamycin. At 72 h post-treatment 13 107 cells were
washed once with 13PBS and incubated with 5 ug mL21
propidium iodide (PI) for 15 minutes at room temperature in
the dark. A heat lysed (HL) control in which half the sample
was lysed by incubation at 708C for 3 min was included to
enable an appropriate live/dead gate to be drawn. Cells
were washed with 13PBS and used to acquire 100,000
events per group by flow cytometry using a MacsQuant
flow cytometer.
In vivo imaging
For imaging, mice were anaesthetized with 4.0% isofluor-
ane/1.5 L O2 per minute and inoculated by subcutaneous
injection with 200 lL of D-luciferin (15 mg mL21 in Mg/Ca-
free Dulbecco’s modified PBS). Light emission was
recorded 10 min after inoculation using an IVIS Spectrum
bioluminescence imaging system (PerkinElmer). Imaging
was performed with an open emission filter, for 30–60 s
exposures, large binning, and 1 f/stop, and captured with a
charge-coupled device (CCD) camera. The absolute unit of
photon emission was given as radiance (photons/second/
cm2/steradian). Images were analysed using Living Image
Software (PerkinElmer) and regions of interest (ROI) of
equal size were selected over the infected footpads to
quantify the amount of photon emission as total photon flux
in photons per second (photons/s).
Statistical analysis
Statistical analysis was performed using GraphPad Prism
5. The analysis of significance of the data was performed
by 2-way ANOVA when comparing data from induced
(1Rap) and uninduced (2Rap) Dcrk3::DICRE/Dcrk3::
CRK3Flox [SSU RE9H] infections and by paired t-test when
comparing footpad sizes.
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